Literature DB >> 9312175

Nitric oxide inhibition of coxsackievirus replication in vitro.

C Zaragoza1, C J Ocampo, M Saura, A McMillan, C J Lowenstein.   

Abstract

Nitric oxide is a radical molecule with antibacterial, -parasitic, and -viral properties. We investigated the mechanism of NO inhibition of Coxsackievirus B3 (CVB3) replication in vitro by determining the effect of NO upon a single replicative cycle of CVB3 grown in HeLa cells. Transfection of inducible NO synthase cDNA into HeLa cells reduces the number of viral particles produced during a single cycle of growth. Similarly, a noncytotoxic concentration of the NO donor S-nitroso-amino-penicillamine reduces the number of viral particles in a dose-dependent manner. To explore the mechanisms by which NO exerts its antiviral effect, we assayed the attachment, replication, and translation steps of the CVB3 life cycle. NO does not affect the attachment of CVB3 to HeLa cells. However, NO inhibits CVB3 RNA synthesis, as shown by a [3H]uridine incorporation assay, reverse transcription-PCR, and Northern analysis. In addition, NO inhibits CVB3 protein synthesis, as shown by [35S]methionine protein labeling and Western blot analysis of infected cells. Thus, NO inhibits CVB3 replication in part by inhibiting viral RNA synthesis by an unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312175      PMCID: PMC508360          DOI: 10.1172/JCI119702

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  78 in total

1.  Coxsackievirus B3 clinical isolates and murine myocarditis.

Authors:  C J Gauntt; M A Pallansch
Journal:  Virus Res       Date:  1996-03       Impact factor: 3.303

2.  Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment.

Authors:  S Mohr; J S Stamler; B Brüne
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

3.  Increased production of nitric oxide in patients infected with the European variant of hantavirus.

Authors:  P H Groeneveld; P Colson; K M Kwappenberg; J Clement
Journal:  Scand J Infect Dis       Date:  1995

Review 4.  The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds.

Authors:  B A Malcolm
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

5.  Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis.

Authors:  P C Tucker; D E Griffin; S Choi; N Bui; S Wesselingh
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 6.  NO inhibitions: antimicrobial properties of nitric oxide.

Authors:  M A De Groote; F C Fang
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

7.  Coxsackievirus-induced chronic myocarditis in murine models.

Authors:  C J Gauntt; S M Tracy; N Chapman; H J Wood; P C Kolbeck; A G Karaganis; C L Winfrey; M W Cunningham
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

8.  Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3.

Authors:  S Mikami; S Kawashima; K Kanazawa; K Hirata; Y Katayama; H Hotta; Y Hayashi; H Ito; M Yokoyama
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

9.  Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.

Authors:  M S Rolph; I A Ramshaw; K A Rockett; J Ruby; W B Cowden
Journal:  Virology       Date:  1996-03-15       Impact factor: 3.616

10.  Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase.

Authors:  Z Mĕlková; M Esteban
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

View more
  27 in total

1.  Viral protease cleavage of inhibitor of kappaBalpha triggers host cell apoptosis.

Authors:  Carlos Zaragoza; Marta Saura; Elizaveta Y Padalko; Ester Lopez-Rivera; Tania R Lizarbe; Santiago Lamas; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-30       Impact factor: 11.205

Review 2.  Does nitric oxide play a critical role in viral infections?

Authors:  C S Reiss; T Komatsu
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis.

Authors:  C Zaragoza; C Ocampo; M Saura; M Leppo; X Q Wei; R Quick; S Moncada; F Y Liew; C J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.

Authors:  Gudrun Szalay; Martina Sauter; Joachim Hald; Andreas Weinzierl; Reinhard Kandolf; Karin Klingel
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

5.  Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.

Authors:  Roland Zell; René Markgraf; Michaela Schmidtke; Matthias Görlach; Axel Stelzner; Andreas Henke; Holger H Sigusch; Brigitte Glück
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

6.  Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.

Authors:  N Fujioka; R Akazawa; K Ohashi; M Fujii; M Ikeda; M Kurimoto
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.

Authors:  Mauro Pires Moraes; Teresa de Los Santos; Marla Koster; Traci Turecek; He Wang; Vladimir G Andreyev; Marvin J Grubman
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

8.  Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  Young-Sun Lee; Na Li; Seungjin Shin; Hee-Sook Jun
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

9.  Pichinde virus induces microvascular endothelial cell permeability through the production of nitric oxide.

Authors:  Rebecca L Brocato; Thomas G Voss
Journal:  Virol J       Date:  2009-10-08       Impact factor: 4.099

10.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.